Endocrine Society Part of Coalition That Developed New Osteoporosis, Fracture Treatment Guidelines

The Endocrine Society recently participated in a coalition of bone health experts, physicians, specialists, and patient advocacy groups to develop clinical care recommendations for the treatment of osteoporosis and resulting hip and spine fractures.

The Secondary Fracture Prevention: Consensus Recommendations from a Multistakeholder Coalition was published online in the peer-reviewed Journal of Bone and Mineral Research.

These recommendations outline the best course of clinical care for women and men, ages 65 years or older, with a hip or vertebral fracture, and emphasize that fracture patients should be managed in a multi-disciplinary clinical system to ensure appropriate evaluation and treatment for osteoporosis and risk of future fractures.

You may also like

  • Coalition of Bone Health Experts Issue Joint Guidance on Managing Osteoporosis in the COVID-19 Era

    The Endocrine Society joined a coalition of leading bone health organizations to release guidance for healthcare professionals treating patients with osteoporosis in the era of COVID-19. The guidelines address the challenges that social distancing has presented for treating patients with osteoporosis, including those who receive treatment through injection or intravenous (IV) delivery of drugs. It also provides guidance on how some patients may be transitioned to alternative therapies until they are able…

  • Bones of Contention: The Unintended Effects of Cancer Therapy

    Therapies that can extend the life of cancer patients often have a negative impact on the skeleton, especially in those being treated for hormone-sensitive cancers. Evidence shows improvements in bone health when bisphosphonates and denosumab are administered. Patients diagnosed with cancer are living longer, with some unanticipated ramifications. According to Facts & Figures 2018, published…

Find more in